Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients

OBJECTIVES: To compare the total number of adverse events (AEs) before and after mesenchymal stromal cell (MSC) infusion in refractory JIA and to evaluate its effectiveness. METHODS: Single-centre Proof of Mechanism Phase Ib, open label intervention study in JIA patients previously failing all biolo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: Swart, Joost F, de Roock, Sytze, Nievelstein, Rutger A J, Slaper-Cortenbach, Ineke C M, Boelens, Jaap J, Wulffraat, Nico M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6758577/
https://ncbi.nlm.nih.gov/pubmed/31070229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez157
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados